Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Molecular Genetics and Metabolism Reports
|
June 5, 2023
An
Jessica Gómez, Laura Artigas, Raquel Valls, et al.
Plos One
|
February 15, 2023
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome
Cristina Segú-Vergés, Laura Artigas, Mireia Coma, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 2023
Unveiling chronic spontaneous urticaria pathophysiology through systems biology
Cristina Segú-Vergés, Jessica Gómez, Pau Terradas-Montana, et al.
Scientific Reports
|
June 21, 2023
Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab
Raquel Valls, Jonathan Wagg, Ido Paz-Priel, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach
Morgane Blanot, Ricardo Pedro Casaroli-Marano, Jordi Mondéjar-Medrano, et al.
Frontiers in Neurology
|
July 12, 2019
Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism
Adrián Martín-Segura, Álvaro Casadomé-Perales, Pietro Fazzari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 28, 2022
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke
Alba Simats, Laura Ramiro, Raquel Valls, et al.
Biomedicines
|
June 24, 2022
Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
Laia Bertran, Ailende Eigbefoh-Addeh, Marta Portillo-Carrasquer, et al.
Plos One
|
October 2, 2020
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
Laura Artigas, Mireia Coma, Pedro Matos-Filipe, et al.
Arthritis Care & Research
|
October 24, 2022
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry
Cristina Fernández-Carballido, Carlos Sanchez-Piedra, Raquel Valls, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Molecular Genetics and Metabolism Reports
|
June 5, 2023
An
Jessica Gómez, Laura Artigas, Raquel Valls, et al.
Plos One
|
February 15, 2023
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome
Cristina Segú-Vergés, Laura Artigas, Mireia Coma, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 2023
Unveiling chronic spontaneous urticaria pathophysiology through systems biology
Cristina Segú-Vergés, Jessica Gómez, Pau Terradas-Montana, et al.
Scientific Reports
|
June 21, 2023
Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab
Raquel Valls, Jonathan Wagg, Ido Paz-Priel, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach
Morgane Blanot, Ricardo Pedro Casaroli-Marano, Jordi Mondéjar-Medrano, et al.
Frontiers in Neurology
|
July 12, 2019
Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism
Adrián Martín-Segura, Álvaro Casadomé-Perales, Pietro Fazzari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 28, 2022
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke
Alba Simats, Laura Ramiro, Raquel Valls, et al.
Biomedicines
|
June 24, 2022
Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
Laia Bertran, Ailende Eigbefoh-Addeh, Marta Portillo-Carrasquer, et al.
Plos One
|
October 2, 2020
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
Laura Artigas, Mireia Coma, Pedro Matos-Filipe, et al.
Arthritis Care & Research
|
October 24, 2022
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry
Cristina Fernández-Carballido, Carlos Sanchez-Piedra, Raquel Valls, et al.
Page
of 2